Randomised controlled double blind study of role of recombinant erythropoietin in the prevention of chronic lung disease

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 76, Issue 3, 1997, Pages

  Griffiths, Gill ^a   Lall, Ranjit ^b   Chatfield, Sue ^c   Short, Andrew ^d   Mackay, Peter ^e   Williamson, Paula ^b   Brown, Julia ^b   Levene, Malcolm I ^a,f  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b Yorkshire Clin Trials and Res Unit   (United Kingdom)

^c BRADFORD ROYAL INFIRMARY   (United Kingdom)

^d HUDDERSFIELD ROYAL INFIRMARY   (United Kingdom)

^e Dewsbury District Hospital   (United Kingdom)

^f UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Blood transfusions; Chronic lung disease; Human erythropoietin; Respiratory support

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; INFANT; INFANT MORTALITY; MULTICENTER STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

BLOOD TRANSFUSION; CHRONIC DISEASE; DOUBLE-BLIND METHOD; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; IRON; LUNG DISEASES; OXYGEN INHALATION THERAPY; RESPIRATION, ARTIFICIAL;

EID: 0030872826     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.76.3.F190     Document Type: Article

References (9)

1. Soll RF, McQueen MC. Respiratory distress syndrome. In: Sinclair JC, Bracken MB, eds. Effective care of the newborn infant. Oxford: Oxford University Press, 1992:325-55
2. Sullivan JL. Iron, plasma antioxidants and the 'oxygen radical disease of prematurity. Am J Dis Child 1988;142: 1341-4.
3. Williamson P, Griffiths G, Norfolk D, Levene M. Blood transfusion and human recombinant erythropoietin in premature newborn infants. Arch Dis Child 1996;75:F65-F8.
4. Machin D, Campbell M. Statistical tables for the design of clinical trials. Oxford: Blackwell Scientific Publications, 1987:132-9.
5. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
6. Gardner MJ, Altman DG. Statistics with confidence. London: British Medical Journal, 1989.
7. Bany-Mohammed FM, Slivka S, Hallman M. Recombinant human erythropoietin: Possible role as an antioxidant in premature rabbits. Pediatr Res 1996;40:381-7.
8. Ohls RK, Hunter DD, Christensen RD. A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia. J Pediatr 1993;123:996-1000.
9. Shannon K. Recombinant erythropoietin in anaemia of prematurity: five years later. Pediatrics 1993;92:614-7.